The global Covid-19 Vaccine market size was valued at US$ million in 2023. With growing demand in downstream market, the Covid-19 Vaccine is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Covid-19 Vaccine market. Covid-19 Vaccine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Covid-19 Vaccine. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Covid-19 Vaccine market.
A COVID-19 vaccine is a hypothetical vaccine against coronavirus disease 2019 (COVID-19). Although no vaccine has completed clinical trials, there are multiple attempts in progress to develop such a vaccine.
The genetic sequence of SARS-CoV-2, the coronavirus that causes COVID-19, was published on 11 January 2020, triggering intense global R&D activity to develop a vaccine against the disease. The scale of the humanitarian and economic impact of the COVID-19 pandemic is driving evaluation of next-generation vaccine technology platforms through novel paradigms to accelerate development, and the first COVID-19 vaccine candidate entered human clinical testing with unprecedented rapidity on 16 March 2020.
The global vaccine R&D effort in response to the COVID-19 pandemic is unprecedented in terms of scale and speed. Given the imperative for speed, there is an indication that vaccine could be available under emergency use or similar protocols by early 2021. This would represent a fundamental step change from the traditional vaccine development pathway, which takes on average over 10 years, even compared with the accelerated 5-year timescale for development of the first Ebola vaccine, and will necessitate novel vaccine development paradigms involving parallel and adaptive development phases, innovative regulatory processes and scaling manufacturing capacity.
North America is the largest consumption place, with a consumption market share nearly 53.8% in 2026, Europe is the second largest consumption place with the consumption market share of 24.61% in 2026.
Key Features:
The report on Covid-19 Vaccine market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Covid-19 Vaccine market. It may include historical data, market segmentation by Type (e.g., DNA, Non-replicating Viral Vector), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Covid-19 Vaccine market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Covid-19 Vaccine market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Covid-19 Vaccine industry. This include advancements in Covid-19 Vaccine technology, Covid-19 Vaccine new entrants, Covid-19 Vaccine new investment, and other innovations that are shaping the future of Covid-19 Vaccine.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Covid-19 Vaccine market. It includes factors influencing customer ' purchasing decisions, preferences for Covid-19 Vaccine product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Covid-19 Vaccine market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Covid-19 Vaccine market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Covid-19 Vaccine market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Covid-19 Vaccine industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Covid-19 Vaccine market.
Market Segmentation:
Covid-19 Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
DNA
Non-replicating Viral Vector
Protein Subunit
RNA
Others
Segmentation by application
Adults
Children
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Moderna
CanSino Biologicals
Inovio Pharmaceuticals
Shenzhen Geno-Immune Medical Institute
GlaxoSmithKine
Pfizer
´³´Ç³ó²Ô²õ´Ç²Ô＆J´Ç³ó²Ô²õ´Ç²Ô
Heat Biologics
Sanofi
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Covid-19 Vaccine Market Size 2019-2030
2.1.2 Covid-19 Vaccine Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Covid-19 Vaccine Segment by Type
2.2.1 DNA
2.2.2 Non-replicating Viral Vector
2.2.3 Protein Subunit
2.2.4 RNA
2.2.5 Others
2.3 Covid-19 Vaccine Market Size by Type
2.3.1 Covid-19 Vaccine Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Covid-19 Vaccine Market Size Market Share by Type (2019-2024)
2.4 Covid-19 Vaccine Segment by Application
2.4.1 Adults
2.4.2 Children
2.5 Covid-19 Vaccine Market Size by Application
2.5.1 Covid-19 Vaccine Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Covid-19 Vaccine Market Size Market Share by Application (2019-2024)
3 Covid-19 Vaccine Market Size by Player
3.1 Covid-19 Vaccine Market Size Market Share by Players
3.1.1 Global Covid-19 Vaccine Revenue by Players (2019-2024)
3.1.2 Global Covid-19 Vaccine Revenue Market Share by Players (2019-2024)
3.2 Global Covid-19 Vaccine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Covid-19 Vaccine by Regions
4.1 Covid-19 Vaccine Market Size by Regions (2019-2024)
4.2 Americas Covid-19 Vaccine Market Size Growth (2019-2024)
4.3 APAC Covid-19 Vaccine Market Size Growth (2019-2024)
4.4 Europe Covid-19 Vaccine Market Size Growth (2019-2024)
4.5 Middle East & Africa Covid-19 Vaccine Market Size Growth (2019-2024)
5 Americas
5.1 Americas Covid-19 Vaccine Market Size by Country (2019-2024)
5.2 Americas Covid-19 Vaccine Market Size by Type (2019-2024)
5.3 Americas Covid-19 Vaccine Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Covid-19 Vaccine Market Size by Region (2019-2024)
6.2 APAC Covid-19 Vaccine Market Size by Type (2019-2024)
6.3 APAC Covid-19 Vaccine Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Covid-19 Vaccine by Country (2019-2024)
7.2 Europe Covid-19 Vaccine Market Size by Type (2019-2024)
7.3 Europe Covid-19 Vaccine Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Covid-19 Vaccine by Region (2019-2024)
8.2 Middle East & Africa Covid-19 Vaccine Market Size by Type (2019-2024)
8.3 Middle East & Africa Covid-19 Vaccine Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Covid-19 Vaccine Market Forecast
10.1 Global Covid-19 Vaccine Forecast by Regions (2025-2030)
10.1.1 Global Covid-19 Vaccine Forecast by Regions (2025-2030)
10.1.2 Americas Covid-19 Vaccine Forecast
10.1.3 APAC Covid-19 Vaccine Forecast
10.1.4 Europe Covid-19 Vaccine Forecast
10.1.5 Middle East & Africa Covid-19 Vaccine Forecast
10.2 Americas Covid-19 Vaccine Forecast by Country (2025-2030)
10.2.1 United States Covid-19 Vaccine Market Forecast
10.2.2 Canada Covid-19 Vaccine Market Forecast
10.2.3 Mexico Covid-19 Vaccine Market Forecast
10.2.4 Brazil Covid-19 Vaccine Market Forecast
10.3 APAC Covid-19 Vaccine Forecast by Region (2025-2030)
10.3.1 China Covid-19 Vaccine Market Forecast
10.3.2 Japan Covid-19 Vaccine Market Forecast
10.3.3 Korea Covid-19 Vaccine Market Forecast
10.3.4 Southeast Asia Covid-19 Vaccine Market Forecast
10.3.5 India Covid-19 Vaccine Market Forecast
10.3.6 Australia Covid-19 Vaccine Market Forecast
10.4 Europe Covid-19 Vaccine Forecast by Country (2025-2030)
10.4.1 Germany Covid-19 Vaccine Market Forecast
10.4.2 France Covid-19 Vaccine Market Forecast
10.4.3 UK Covid-19 Vaccine Market Forecast
10.4.4 Italy Covid-19 Vaccine Market Forecast
10.4.5 Russia Covid-19 Vaccine Market Forecast
10.5 Middle East & Africa Covid-19 Vaccine Forecast by Region (2025-2030)
10.5.1 Egypt Covid-19 Vaccine Market Forecast
10.5.2 South Africa Covid-19 Vaccine Market Forecast
10.5.3 Israel Covid-19 Vaccine Market Forecast
10.5.4 Turkey Covid-19 Vaccine Market Forecast
10.5.5 GCC Countries Covid-19 Vaccine Market Forecast
10.6 Global Covid-19 Vaccine Forecast by Type (2025-2030)
10.7 Global Covid-19 Vaccine Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Moderna
11.1.1 Moderna Company Information
11.1.2 Moderna Covid-19 Vaccine Product Offered
11.1.3 Moderna Covid-19 Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Moderna Main Business Overview
11.1.5 Moderna Latest Developments
11.2 CanSino Biologicals
11.2.1 CanSino Biologicals Company Information
11.2.2 CanSino Biologicals Covid-19 Vaccine Product Offered
11.2.3 CanSino Biologicals Covid-19 Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 CanSino Biologicals Main Business Overview
11.2.5 CanSino Biologicals Latest Developments
11.3 Inovio Pharmaceuticals
11.3.1 Inovio Pharmaceuticals Company Information
11.3.2 Inovio Pharmaceuticals Covid-19 Vaccine Product Offered
11.3.3 Inovio Pharmaceuticals Covid-19 Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Inovio Pharmaceuticals Main Business Overview
11.3.5 Inovio Pharmaceuticals Latest Developments
11.4 Shenzhen Geno-Immune Medical Institute
11.4.1 Shenzhen Geno-Immune Medical Institute Company Information
11.4.2 Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Product Offered
11.4.3 Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Shenzhen Geno-Immune Medical Institute Main Business Overview
11.4.5 Shenzhen Geno-Immune Medical Institute Latest Developments
11.5 GlaxoSmithKine
11.5.1 GlaxoSmithKine Company Information
11.5.2 GlaxoSmithKine Covid-19 Vaccine Product Offered
11.5.3 GlaxoSmithKine Covid-19 Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 GlaxoSmithKine Main Business Overview
11.5.5 GlaxoSmithKine Latest Developments
11.6 Pfizer
11.6.1 Pfizer Company Information
11.6.2 Pfizer Covid-19 Vaccine Product Offered
11.6.3 Pfizer Covid-19 Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Pfizer Main Business Overview
11.6.5 Pfizer Latest Developments
11.7 ´³´Ç³ó²Ô²õ´Ç²Ô＆J´Ç³ó²Ô²õ´Ç²Ô
11.7.1 ´³´Ç³ó²Ô²õ´Ç²Ô＆J´Ç³ó²Ô²õ´Ç²Ô Company Information
11.7.2 ´³´Ç³ó²Ô²õ´Ç²Ô＆J´Ç³ó²Ô²õ´Ç²Ô Covid-19 Vaccine Product Offered
11.7.3 ´³´Ç³ó²Ô²õ´Ç²Ô＆J´Ç³ó²Ô²õ´Ç²Ô Covid-19 Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 ´³´Ç³ó²Ô²õ´Ç²Ô＆J´Ç³ó²Ô²õ´Ç²Ô Main Business Overview
11.7.5 ´³´Ç³ó²Ô²õ´Ç²Ô＆J´Ç³ó²Ô²õ´Ç²Ô Latest Developments
11.8 Heat Biologics
11.8.1 Heat Biologics Company Information
11.8.2 Heat Biologics Covid-19 Vaccine Product Offered
11.8.3 Heat Biologics Covid-19 Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Heat Biologics Main Business Overview
11.8.5 Heat Biologics Latest Developments
11.9 Sanofi
11.9.1 Sanofi Company Information
11.9.2 Sanofi Covid-19 Vaccine Product Offered
11.9.3 Sanofi Covid-19 Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Sanofi Main Business Overview
11.9.5 Sanofi Latest Developments
12 Research Findings and Conclusion
Ìý
Ìý
*If Applicable.
